Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients

Chest

Volumn 113, Issue 3, 1998, Pages 587-592

  Boulet, Louis Philippe ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Asthma; Asthma treatment; Compliance; Education; Inhaled corticosteroids; Patients' perception

Indexed keywords

BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID;

ARTICLE; ASTHMA; BONE DENSITY; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG TOLERANCE; FEMALE; HEALTH SURVEY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PRIORITY JOURNAL; SIDE EFFECT; STEROID THERAPY;

EID: 0031913201     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.113.3.587     Document Type: Article

References (23)

1. Britton J. Asthma's changing prevalence, [editorial]. BMJ 1992; 304:857-58
2. Wilkins K, Mao Y. Trends in rate of admission to hospital and death from asthma among children and young adults in Canada during the 1980s. Can Med Assoc J 1993; 148:185-90
3. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med 1992; 326:862-66
4. International consensus report on diagnosis and treatment of asthma. Clin Exp Allergy 1992;22(suppl 1):1-72
5. British Thoracic Society. Guidelines for the management of asthma: a summary. BMJ 1993; 306:776-82
6. Ernst P, FitzGerald JM, Spier S. Canadian asthma consensus conference: summary of recommendations, Can Respir J 1996; 3:89-100
7. Bousquet J, Knani J, Henry C, et al. Undertreatment in a nonselected population of adult patients with asthma. J Allergy Clin Immunol 1996; 98:514-21
8. Horn CR, Clark TJH, Cochrane GM. Compliance with inhaled therapy and morbidity from asthma. Respir Med 1990; 84:67-70
9. Mellis RB, Evans D, Zimmerman B, et al. Patient compliance: are we wasting our time and don't know it? Am Rev Respir Dis 1992; 146:1376-77
10. Sockrider MM, Wolle JM. Helping patients better adhere to treatment regimen. J Respir Dis 1996; 17:204-16
11. Sackett DL. The magnitude of compliance and non-compliance. In: Sackett DL, Taylor DW, Haynes RB, eds. Compliance with therapeutic regimens. Baltimore: Johns Hopkins University Press, 1979
12. Spector SL, Kinsman R, Mawhinney H, et al. Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled trials. J Allergy Clin Immunol 1986; 77:65-70
13. Hand CH, Bradley C. Health beliefs of adults with asthma: towards an understanding of the difference between symptomatic and preventive use of inhaler treatment. J Asthma 1996; 33:331-38
14. Ernst P, Hemmelgarn B, Cockcroft DW. Overreliance on bronchodilators as a risk factor for life-threatening asthma. Can Respir J 1995; 2:34-39
15. Spitzer WO, Suissa S, Ernst P, et al. The use of β-agonists and the risk of death and near death from asthma. N Engl J Med 1992; 326:501-06
16. Ernst P, Spitzer W, Suissa S, et al. Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA 1992; 268:3462-64
17. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991;87:893-910
18. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Bespir Dis 1993; 148(suppl):S1-S26
19. Osman LM, Russell IT, Friend JAR, et al. Predicting patient attitudes to asthma medication. Thorax 1993; 48:827-30
20. Adelroth E, Thompson S. Advantages of high-dose inhaled hudesonide [letter]. Lancet 1988; 1:476
21. Becker MU, Maiman LA. Strategies for enhancing patient compliance. J Community Health 1980; 6:113-15
22. Boulet LF, Chapman KR, Green LW, et al. Asthma education. Chest 1994; 106:184S-96S
23. Brewis RAL. Patient education, sell-management plans and peak flow measurements. Respir Med 1991; 85:457-62